Abstract：OBJECTIVE: To investigate the resistance of Helicobacter pylori (H.pylori) to antimicrobial agents in adolescents. METHODS: One hundred and eight adolescents (6-18 years old) underwent a gastroscopy examination. H.pylori strains were isolated from gastric mucosa. Antimicrobial susceptibility testing was performed by means of Kirby-Baner. RESULTS: Thirty-six H.pylori strains were identified. The resistant rate of H.pylori strains to clarithromycin, fruranzolidone and amoxicillin was 8.3%, 16.7% and 33.3%, respectively. H.pylori strains showed a high resistance to metronidazole (94.4%), while no strain was resistant to gentamicin and levofloxacin. CONCLUSIONS:The H.pylori strains from the adolescents in Zhejiang showed a high resistance to metronidazole and amoxicillin but a low resistance to clarithromycin and fruranzolidone. All of H.pylori strains were susceptive to gentamicin and levofloxacin.［Chin J Contemp Pediatr, 2009, 11 (3):210-212］
［5］Bazzoli F, Pozzato P. Therapy of H.pylori infection［J］. J Physiol Pharmacol, 1997, 48 （4 Suppl）:39-46.
［6］Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy［J］.Gastroenterology, 1992, 102(2):493-496.
［7］Peitz U, Sulliga M, Wolle K, Leodolter A, Von Arnim U, Kahl S, et al. High rate of post-therapeutic resistance after failure of macrolide-nitromidazole triple therapy to cure Helicobacter pylori infection:impact of two second-line therapies in a randomized study［J］. Aliment Pharmacol Ther, 2002, 16(2):315-324.
［8］Dzierzanowska-Fangrat K, Rozynek E, Józwiak P, Celińska-Cedro D, Madalinski K, Dzierzano-wska D. Primary resistance to Clarithromycin inclinical strains of Helicobacter pylori isolated from children in Poland［J］. Int J Antimicrob Agents, 2001, 18(4):387-390.
［9］Boyanova L, Gergova G, Nikolov R, Davidkov L, Kamburov V, Jelev C, et al. Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods［J］. Diagn Microbiol Infect Dis, 2008, 60(4):409-415.
［10］Boyanova L, Stancheva I, Spassova Z, Katzarov N, Mitov I, Koumanova R. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia,Bulgaria［J］. J Med Microbiol, 2000, 49(5):415-418.
［13］DiCaro S, Zocco MA, Cremonini F, Candelli M, Nista EC, Bartolozzi F, et al. Levofloxacin based regimens for the eradication of Helicobacter pylori［J］. Eur J Gastroenterol Hepatol, 2002, 14(12):1309-1312.
［14］Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori［J］. Antimicrob Agents Chemother, 1996, 40(2):477-480.
